Surgepays (NASDAQ:SURG) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.19) by 168.42 percent. This is a 34.21 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $15.984 million which beat the analyst consensus estimate of $15.495 million by 3.16 percent. This is a 51.12 percent increase over sales of $10.577 million the same period last year.